Medical Stock Spotlight

August 2012
MondayMorning;8/20/2012, Vol. 20 Issue 33, p1
The article offers news briefs related to pharmaceutical industry as of August 20, 2012. It states that stock market of AMN Healthcare Services Inc. in San Diego, California rose from 1.20 U.S. dollars to 7.75 U.S. dollars and Savient Pharmaceuticals Inc. in Bridgewater, New Jersey leaped to1.00 U.S. dollars. It also states that Sarepta Therapeutics Inc. in Cambridge, Massachusetts gave a positive sign in its market share and position as its stock market rose to 10.07 US dollars.


Related Articles

  • Seeking a buyer as drug goes to market. Kaltwasser, Jared // njbiz;11/1/2010, Vol. 23 Issue 44, p3 

    The article reports on the plan of Savient Pharmaceuticals Inc. to move forward with the launch of its lead drug Krystexxa for the treatment of chronic gout in adults.

  • Savient Shares Tumble on Extension Safety Data.  // Bioworld Week;11/3/2008, Vol. 16 Issue 44, p3 

    The article reports on the decrease in the shares of Savient Pharmaceuticals Inc. following the company's presentation of data on its pegloticase (Puricase) for treatment-resistant gout in the U.S. Analysts' main concerns are the safety issue of the drug and the size of its market. The company...

  • Savient sells its biologics.  // Chemical Market Reporter;3/28/2005, Vol. 267 Issue 13, p2 

    Reports that Savient Pharmaceuticals Inc. has shed its global biologics manufacturing operations to two subsidiaries of Lausanne, Switzerland-based biopharmaceutical Ferring Holding SA. Amount that will be paid by Ferring; Global rights gained by Ferring to human growth hormone and other products.

  • AMN Healthcare Announces Its Completion of New Credit Agreement. Allen, Mike // San Diego Business Journal;4/16/2012, Vol. 33 Issue 16, p17 

    The article reports that San Diego, California-based nurse staffing company AMN Healthcare Services Inc. has secured refinancing for its existing credit facility.

  • UBS Pharma Forum Yields M&A Sound Bites. Cohen, Judy Radler // Mergers & Acquisitions Report;5/1/2006, Vol. 19 Issue 17, p3 

    Reports on speculations regarding the possible spinoff of Rosemont Pharmaceuticals by Savient Pharmaceuticals Inc. Market capitalization review of Rosemont conducted by Savient according to remarks by CEO Christopher Clement at the 2006 UBS Global Specialty Pharmaceuticals Conference in New...

  • FDA Gout Route Unimpeded, but Will Docs Jump Aboard? Osborne, Randy // BioWorld Insight;3/29/2010, Vol. 18 Issue 13, p2 

    The article offers updates on various pharmaceutical companies including Savient Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., and BioCryst Pharmaceuticals Inc. New Jersey-based Savient resubmits its biologics license application for Krystexxa in refractory patients. Takeda in Japan...

  • Watch Out For A Dangerous One-Two Punch.  // RN;Dec2004, Vol. 67 Issue 12, p72 

    Reports on Savient Pharmaceuticals Inc.'s issuance of a safety alert to nurses and other healthcare professionals regarding a possibly serious interaction between its anabolic steroid oxandroline (Oxandrin) and warfarin (Coumadin). Use of oxadrolone to promote weight gain; Evidence that...

  • FREE DOC SEARCHES.  // Trustee;Oct2002, Vol. 55 Issue 9, p3 

    Focuses on the pro bono physician search program offered by Merritt, Hawkins & Associates, a physician search firm based in Irving, Texas. Purpose of the program; Medical facilities which are qualified for the program; Information on the shortage of physicians at Bayside Community Hospital in...

  • Nurse Staffing Firm Reports Loss in 'Challenging' Times. Chambers, Heather // San Diego Business Journal;3/15/2010, Vol. 31 Issue 11, p7 

    The article reports that staffing firm AMN Healthcare Services Inc. has reported corporate loss worth 2.7 million dollars for the first quarter of 2010 in San Diego, California.


Other Topics